| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2855 | |||||||||||||||||||||||
| Submitter : | Mrs. Maria Acosta | Date & Time: | 12/11/2006 10:12:11 | |||||||||||||||||||||
| Organization : | Mrs. Maria Acosta | |||||||||||||||||||||||
| Category : | Drug Industry | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| Please when producing vaccinations do not use fetal stem cells. There are many people who have ethical problems with the use of stem cells from aborted fetuses being used to develop vaccines. Many people want to have an ethical alternative. | ||||||||||||||||||||||||